chr12-21437752-C-G

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6

The NM_024854.5(PYROXD1):ā€‹c.22C>Gā€‹(p.Pro8Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,612,968 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.000053 ( 0 hom., cov: 33)
Exomes š‘“: 0.000016 ( 0 hom. )

Consequence

PYROXD1
NM_024854.5 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -1.46
Variant links:
Genes affected
PYROXD1 (HGNC:26162): (pyridine nucleotide-disulphide oxidoreductase domain 1) This gene encodes a nuclear-cytoplasmic pyridine nucleotide-disulphide reductase (PNDR). PNDRs are flavoproteins that catalyze the pyridine nucleotide-dependent reduction of thiol residues in other proteins. The encoded protein belongs to the class I pyridine nucleotide-disulphide oxidoreductase family but lacks the C-terminal dimerization domain found in other family members and instead has a C-terminal nitrile reductase domain. It localizes to the nucleus and to striated sarcomeric compartments. Naturally occurring mutations in this gene cause early-onset myopathy with internalized nuclei and myofibrillar disorganization. A pseudogene of this gene has been defined on chromosome 11. [provided by RefSeq, Apr 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.026114285).
BP6
Variant 12-21437752-C-G is Benign according to our data. Variant chr12-21437752-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1409544.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PYROXD1NM_024854.5 linkuse as main transcriptc.22C>G p.Pro8Ala missense_variant 1/12 ENST00000240651.14
PYROXD1XM_047429554.1 linkuse as main transcriptc.22C>G p.Pro8Ala missense_variant 1/10
PYROXD1XM_006719153.4 linkuse as main transcriptc.22C>G p.Pro8Ala missense_variant 1/8
PYROXD1NM_001350913.2 linkuse as main transcriptc.-682C>G 5_prime_UTR_variant 1/11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PYROXD1ENST00000240651.14 linkuse as main transcriptc.22C>G p.Pro8Ala missense_variant 1/121 NM_024854.5 P1Q8WU10-1
PYROXD1ENST00000544970.5 linkuse as main transcriptc.22C>G p.Pro8Ala missense_variant, NMD_transcript_variant 1/111
PYROXD1ENST00000543476.5 linkuse as main transcriptc.22C>G p.Pro8Ala missense_variant, NMD_transcript_variant 1/95
PYROXD1ENST00000375266.8 linkuse as main transcriptc.22C>G p.Pro8Ala missense_variant, NMD_transcript_variant 1/135

Frequencies

GnomAD3 genomes
AF:
0.0000525
AC:
8
AN:
152238
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000205
AC:
5
AN:
244188
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
132864
show subpopulations
Gnomad AFR exome
AF:
0.000262
Gnomad AMR exome
AF:
0.0000292
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000164
AC:
24
AN:
1460730
Hom.:
0
Cov.:
33
AF XY:
0.0000165
AC XY:
12
AN XY:
726544
show subpopulations
Gnomad4 AFR exome
AF:
0.000119
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000144
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000525
AC:
8
AN:
152238
Hom.:
0
Cov.:
33
AF XY:
0.0000403
AC XY:
3
AN XY:
74372
show subpopulations
Gnomad4 AFR
AF:
0.000145
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000756
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000330
AC:
4
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpAug 10, 2022This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 8 of the PYROXD1 protein (p.Pro8Ala). This variant is present in population databases (rs370239493, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with PYROXD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1409544). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The alanine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsJan 03, 2024This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.046
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
0.73
DANN
Benign
0.71
DEOGEN2
Benign
0.0095
T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.055
N
LIST_S2
Benign
0.40
T
M_CAP
Benign
0.0027
T
MetaRNN
Benign
0.026
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.27
N
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
0.86
N
REVEL
Benign
0.011
Sift
Benign
0.88
T
Sift4G
Benign
0.94
T
Polyphen
0.0
B
Vest4
0.13
MVP
0.030
MPC
0.14
ClinPred
0.012
T
GERP RS
-5.9
Varity_R
0.012
gMVP
0.31

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs370239493; hg19: chr12-21590686; API